Pelthos Therapeutics PTHS
NYSE PTHS
$8.97 -0.40 (-4.27%)
As of: Nov 10, 2026 · 3:59 PM EST

Pelthos Therapeutics (PTHS) Non-Current Assets (2025 - 2026)

Updated

Pelthos Therapeutics' Non-Current Assets was $74 million in Q2 2026, down 2.1% from the prior quarter.

Analysis

Pelthos Therapeutics (PTHS) Non-Current Assets (2025 - 2026) Analysis & Trends

At the end of FY2025, Non-Current Assets at Pelthos Therapeutics came in at $76.99 million.

  • Per Business Quant data, PTHS's Non-Current Assets in the three quarters before Q2 2026 was $75.58 million (Q1 2026), $76.99 million (Q4 2025) and $76.67 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Assets (Qtr)
1 Eli Lilly 1,264.65 Bn 1,238.27 Bn 20.46 Bn 82.81 Bn
2 Johnson & Johnson 677.74 Bn 597.60 Bn 17.30 Bn 141.07 Bn
3 AbbVie 517.10 Bn 485.11 Bn 13.12 Bn 110.20 Bn
4 Merck 362.23 Bn 325.17 Bn 13.19 Bn 75.00 Mn
5 Novartis Ag 315.90 Bn 276.16 Bn 11.24 Bn 94.68 Bn
6 Astrazeneca 289.40 Bn 266.24 Bn 12.86 Bn 87.87 Bn
7 Amgen 249.90 Bn 201.56 Bn 7.58 Bn 61.69 Bn
8 Gilead Sciences 209.15 Bn 184.26 Bn 6.73 Bn 34.86 Bn
9 Pfizer 165.88 Bn 113.23 Bn 12.56 Bn 159.99 Bn
10 Pelthos Therapeutics 32.83 Mn -55.57 Mn 11.99 Mn 74.00 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 74.00 Mn
Mar 31, 2026 75.58 Mn
Dec 31, 2025 76.99 Mn
Sep 30, 2025 76.67 Mn
API Access

Pelthos Therapeutics Non-Current Assets API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-assets&ticker=PTHS&period=max&api_key=YOUR_API_KEY